NEW YORK (GenomeWeb News) — PerkinElmer on Monday said it plans to buy back as much as 10 million shares of its common stock over the next four years.

PerkinElmer’s board authorized the buyback, which will be made over the open market or “through privately negotiated transactions,” the company said.

Two weeks ago, PerkinElmer reported that third-quarter revenues rose 7 percent as profirs slid 7 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.